01053nas a2200301 4500000000100000008004100001260001300042653001500055653001000070653002900080653001200109653001100121653001100132653001200143653000900155653001600164653001300180100001200193700001400205700001200219700001600231245006400247300001100311490000700322050003200329520037600361022001400737 1976 d c1976 Oct10aAdolescent10aAdult10aClinical Trials as Topic10aDapsone10aFemale10aHumans10aleprosy10aMale10aMiddle Aged10aRifampin1 aGhosh S1 aHazra S K1 aKundu S1 aChoudhury S00aClinical trial with rifampicin in the treatment of leprosy. a775-800 v48 aInfolep Library - available3 a
Rusults of treatment with Rifampicin in ten untreated and uncomplicated cases of active lepromatous leprosy are compared with those of D.D.S. in a similar number of cases. Though clinical improvement was similar in both the groups, improvement in B.I. and M.I. appears to be better in the latter group. High price of Rifampicin is its greatest drawback at present.
a0024-1024